Business Description
Cassava Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US14817C1071
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -112.6 | |||||
3-Year EPS without NRI Growth Rate | -109.3 | |||||
3-Year FCF Growth Rate | -112.1 | |||||
3-Year Book Growth Rate | 7.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.66 | |||||
9-Day RSI | 45.38 | |||||
14-Day RSI | 50.34 | |||||
6-1 Month Momentum % | 38.14 | |||||
12-1 Month Momentum % | 19.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.07 | |||||
Quick Ratio | 4.07 | |||||
Cash Ratio | 3.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -10.39 | |||||
ROA % | -8.35 | |||||
ROIC % | -370.59 | |||||
3-Year ROIIC % | -449.24 | |||||
ROC (Joel Greenblatt) % | -604.26 | |||||
ROCE % | -89.25 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 102.01 | |||||
PB Ratio | 6.94 | |||||
Price-to-Tangible-Book | 6.93 | |||||
EV-to-EBIT | -9.02 | |||||
EV-to-EBITDA | -9.11 | |||||
EV-to-Forward-Revenue | 5.95 | |||||
EV-to-FCF | -13.8 | |||||
Price-to-Net-Current-Asset-Value | 7.83 | |||||
Price-to-Net-Cash | 8.6 | |||||
Earnings Yield (Greenblatt) % | -11.09 | |||||
FCF Yield % | -6.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cassava Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.305 | ||
Beta | -2.31 | ||
Volatility % | 47.31 | ||
14-Day RSI | 50.34 | ||
14-Day ATR (€) | 1.408121 | ||
20-Day SMA (€) | 25.8995 | ||
12-1 Month Momentum % | 19.63 | ||
52-Week Range (€) | 7.844 - 38 | ||
Shares Outstanding (Mil) | 47.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cassava Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cassava Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cassava Sciences Inc Frequently Asked Questions
What is Cassava Sciences Inc(FRA:PX91)'s stock price today?
When is next earnings date of Cassava Sciences Inc(FRA:PX91)?
Does Cassava Sciences Inc(FRA:PX91) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |